Neurocrine Biosciences Inc (NBIX)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
$115.00
Buy
$134.00
$2.46 (+2.05%)
Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
Prices updated at 27 May 2025, 21:28 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
$122.78 - $119.62 | |
$157.98 - $84.23 | |
- | |
12,137.17m | |
41.57 | |
- | |
1,283,685 | |
4.79 | |
1,131,402.67 | |
0.22 | |
99.40m | |
US64125C1099 | |
2.95 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.